Creatine Ultra
Natural health product licensed in Canada
- Other names
- Cellugreen Creatine
- Licence holder
- NorthMED Life Sciences Inc.
- NPN or DIN-HM
- 80059289
- Status
- Active licence
- Licence date
- 26 March 2015
- Revision date
- 7 January 2026
- Form
- Poudre
- Route of administration
- Orale
- Application type
- Officinale
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| N-(Aminoiminométhyl)-N-méthylglycine monohydraté Source : Créatine monohydratée | 5 g | Not calculated |
Non-medicinal ingredients
Not provided.
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 5 g | minimum: 3 Tous les jours ; maximum: 4 Tous les jours |
| Adultes | Not specified | 5 g | 1 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Increases [fat-free/body/muscle/lean] [mass/size] when used in conjunction with a resistance training regimen. Improves [strength/power/performance] in repetitive bouts of brief, highly-intense physical activity (e.g. sprints, jumping, resistance training) (by increasing [muscle/intramuscular] [creatine/phosphocreatine/energy] levels).
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Consult a health care practitioner prior to use if you have a kidney disorder. Consult a health care practitioner prior to use if you are pregnant or breastfeeding. May result in weight gain.
Source
Official Health Canada record, licence 80059289
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
Has the product changed? Photograph the packaging.